Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5868 Target Snapshot

Nuclear receptor ROR-alpha · SINGLE PROTEIN · Homo sapiens

414Compounds
115Assays
1Approved Drugs
354.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P35398. Use UniProt P35398 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P35398 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Nuclear receptor ROR-alpha as ChEMBL target CHEMBL5868, mapped to UniProt P35398. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Nuclear receptor ROR-alpha
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5868
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P35398
Nuclear receptor ROR-alpha
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Nuclear receptor ROR-alpha is the right protein anchor across sources, using UniProt P35398 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNuclear receptor ROR-alpha
UniProt AccessionP35398
Component TypeProtein
Sequence Length523 aa

Nuclear receptor ROR-alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Nuclear receptor ROR-alpha, mapped to UniProt P35398. Sequence length is 523 aa.

Mapped IDP35398
Review nameNuclear receptor ROR-alpha
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase I
Assay Mix

Activity Type Distribution

IC50194.0
KI25.0
EC50134.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL497834 7.92 Ki 12.0 Preclinical
CHEMBL497207 7.92 Ki 12.0 Preclinical
CHEMBL1278177 7.92 Ki 12.0 Preclinical
CHEMBL3314003 7.54 EC50 29.0 Preclinical
CHEMBL3617295 7.07 EC50 86.0 Preclinical
CHEMBL4225808 6.96 IC50 110.0 Preclinical
CHEMBL62136 6.88 Ki 132.0 Preclinical
CHEMBL3094388 6.76 Ki 172.0 Preclinical
CHEMBL3617309 6.7 EC50 200.0 Preclinical
CHEMBL38 6.7 IC50 199.53 Approved
Distribution

pChEMBL Value Distribution

60
5.0
32
5.5
7
6.0
9
6.5
1
7.0
4
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TRETINOIN
CHEMBL38
Approved 1971
Assay Landscape

Assay Landscape

115
Total Assays
127
Tested Compounds
3
Assay Types
Binding — 111 assays, 127 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 61 70 5.5
single protein format 49 57 5.3
assay format 1 0
Functional — 3 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 2 6.2
assay format 1 0
Unassigned — 1 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 5 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine